← All Sponsors

SPONSOR

University of Rochester

Total Trials

12

Recruiting

12

Phases

Phase 2, Phase 3

Conditions studied: Breast Cancer Myeloid Malignancy Acute Myeloid Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasm Myelofibrosis Lymphoma Malignant Solid Neoplasm Stroke, Ischemic Quadrantanopia

NCT04965064 Phase 2

Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling

A Telehealth Advance Care Planning Intervention

Myeloid Malignancy

NCT05006482 Phase 3

Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial

Vision Loss Impact on Navigation in Virtual Reality

Stroke, Ischemic

NCT05597345 Phase 2

Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma

Smoldering Multiple Myeloma

Expecting Mother's Study of Consumption or Avoidance of Peanut and Egg

Allergy and Immunology

Comparison of Two Types of Bone Grafts in Patients Who Need One of Their Front Teeth Removed and Replaced With an Implant

Ridge Preservation

Meningitis: Burden, Causes, Screening and Prevention in Rural Northern Uganda

Families Moving Forward (FMF) Connect Pro for Mental Health Providers

Fetal Alcohol Spectrum Disorders

TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.

Stress Incontinence Female

Intervening on Opioid Use and Loneliness

Opioid Use Disorder

NCT06068543 Phase 2

Reducing Frailty for Older Cancer Survivors Using Supplements II